1
|
Romano A, Liparoti M, Minino R, Polverino A, Cipriano L, Carotenuto A, Tafuri D, Sorrentino G, Sorrentino P, Troisi Lopez E. The effect of dopaminergic treatment on whole body kinematics explored through network theory. Sci Rep 2024; 14:1913. [PMID: 38253728 PMCID: PMC10803322 DOI: 10.1038/s41598-023-50546-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2023] [Accepted: 12/21/2023] [Indexed: 01/24/2024] Open
Abstract
Three-dimensional motion analysis represents a quantitative approach to assess spatio-temporal and kinematic changes in health and disease. However, these parameters provide only segmental information, discarding minor changes of complex whole body kinematics characterizing physiological and/or pathological conditions. We aimed to assess how levodopa intake affects the whole body, analyzing the kinematic interactions during gait in Parkinson's disease (PD) through network theory which assess the relationships between elements of a system. To this end, we analysed gait data of 23 people with PD applying network theory to the acceleration kinematic data of 21 markers placed on participants' body landmarks. We obtained a matrix of kinematic interactions (i.e., the kinectome) for each participant, before and after the levodopa intake, we performed a topological analysis to evaluate the large-scale interactions among body elements, and a multilinear regression analysis to verify whether the kinectome's topology could predict the clinical variations induced by levodopa. We found that, following levodopa intake, patients with PD showed less trunk and head synchronization (p-head = 0.048; p-7th cervical vertebrae = 0.032; p-10th thoracic vertebrae = 0.006) and an improved upper-lower limbs synchronization (elbows right, p = 0.002; left, p = 0.005), (wrists right, p = 0.003; left, p = 0.002; knees right, p = 0.003; left, p = 0.039) proportional to the UPDRS-III scores. These results may be attributable to the reduction of rigidity, following pharmacological treatment.
Collapse
Affiliation(s)
- Antonella Romano
- Department of Medical, Motor and Wellness Sciences, University of Naples "Parthenope", Naples, Italy
| | - Marianna Liparoti
- Department of Philosophical, Pedagogical and Economic-Quantitative Sciences, University of Chieti-Pescara G. D'Annunzio, Chieti, Italy
| | - Roberta Minino
- Department of Medical, Motor and Wellness Sciences, University of Naples "Parthenope", Naples, Italy
| | - Arianna Polverino
- Institute of Diagnosis and Treatment Hermitage Capodimonte, Naples, Italy
| | - Lorenzo Cipriano
- Department of Medical, Motor and Wellness Sciences, University of Naples "Parthenope", Naples, Italy
| | | | - Domenico Tafuri
- Department of Medical, Motor and Wellness Sciences, University of Naples "Parthenope", Naples, Italy
| | - Giuseppe Sorrentino
- Department of Medical, Motor and Wellness Sciences, University of Naples "Parthenope", Naples, Italy
- Institute of Diagnosis and Treatment Hermitage Capodimonte, Naples, Italy
- Institute of Applied Sciences and Intelligent Systems of National Research Council, Pozzuoli, Italy
| | - Pierpaolo Sorrentino
- Institut de Neurosciences Des Systèmes, Inserm, INS, Aix-Marseille University, Marseille, France.
- Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
| | - Emahnuel Troisi Lopez
- Institute of Applied Sciences and Intelligent Systems of National Research Council, Pozzuoli, Italy
| |
Collapse
|
2
|
Petracca M, Carotenuto A, Scandurra C, Moccia M, Rosa L, Arena S, Ianniello A, Nozzolillo A, Turrini M, Streito LM, Abbadessa G, Cellerino M, Bucello S, Ferraro E, Mattioli M, Chiodi A, Inglese M, Bonavita S, Clerico M, Cordioli C, Moiola L, Patti F, Lavorgna L, Filippi M, Borriello G, D'Amico E, Pozzilli C, Brescia Morra V, Lanzillo R. Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors. Mult Scler Relat Disord 2023; 78:104907. [PMID: 37523809 DOI: 10.1016/j.msard.2023.104907] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2022] [Revised: 07/14/2023] [Accepted: 07/21/2023] [Indexed: 08/02/2023]
Abstract
BACKGROUND Although multiple sclerosis (MS) Intimacy and Sexuality Questionnaire-19 (MSISQ-19) is a widely applied tool, no unique definition of sexual dysfunction (SD) based on its score exists. OBJECTIVE To explore the impact of different MSISQ-19 cut-offs on SD prevalence and associated risk factors, providing relevant information for its application in research and clinical settings. METHODS After defining SD according to two different MSISQ-19 cut-offs in 1155 people with MS (pwMS), we evaluated SD prevalence and association with sociodemographic and clinical features, mood status and disability via logistic regression. RESULTS Depending on the chosen cut-off, 45% to 54% of pwMS reported SD. SD defined as MSISQ-19 score >30 was predicted by age (OR=1.01, p=0.047), cognition (OR=0.96, p=0.004) and anxiety (OR=1.03, p=0.019). SD defined as a score >3 on any MSISQ-19 item was predicted by motor disability (OR=1.12, p=0.003) and cognition (OR= 0.96, p=0.002). CONCLUSION Applying different MSISQ-19 cut-offs influences both the estimated prevalence and the identification of risk factors for SD, a finding that should be considered during study planning and data interpretation. Preserved cognition exerts a protective effect towards SD regardless from the specific study setting, representing a key point for the implementation of preventive and therapeutic strategies.
Collapse
Affiliation(s)
- M Petracca
- Department of Neurosciences and Reproductive and Odontostomatological Sciences, University of Naples Federico II, Via Pansini 5, Naples 810145, Italy
| | - A Carotenuto
- Department of Neurosciences and Reproductive and Odontostomatological Sciences, University of Naples Federico II, Via Pansini 5, Naples 810145, Italy
| | - C Scandurra
- Department of Neurosciences and Reproductive and Odontostomatological Sciences, University of Naples Federico II, Via Pansini 5, Naples 810145, Italy
| | - M Moccia
- Department of Molecular Medicine and Medical Biotechnology, Federico II University of Naples, Italy; MS Unit, Federico II University Hospital, Naples, Italy
| | - L Rosa
- Department of Public Health, University of Naples Federico II, Naples, Italy
| | - S Arena
- Department "G.F. Ingrassia", MS Center, University of Catania, Catania, Italy
| | - A Ianniello
- MS Center, S. Andrea Hospital, Sapienza University of Rome, Rome, Italy
| | - A Nozzolillo
- Multiple Sclerosis Center, Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - M Turrini
- Centro Sclerosi Multipla, ASST Spedali Civili di Brescia, Ospedale di Montichiari, Brescia, Italy
| | - L M Streito
- San Luigi Gonzaga Academic Hospital, Orbassano, TO 10043, Italy
| | - G Abbadessa
- Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - M Cellerino
- Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy
| | - S Bucello
- Multiple Sclerosis Centre, "E. Muscatello" Hospital - ASP8, Augusta, SR, Italy
| | - E Ferraro
- S. Filippo Neri Hospital, Rome, Italy
| | - M Mattioli
- NCL-Istituto di Neuroscienze Gruppo Neuromed, Rome, Italy
| | - A Chiodi
- Intradepartmental Program of Clinical Psychology, Federico II University Hospital, Naples, Italy
| | - M Inglese
- Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genoa, Italy
| | - S Bonavita
- Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - M Clerico
- San Luigi Gonzaga Academic Hospital, Orbassano, TO 10043, Italy; Department of Clinical and Biological Sciences, University of Torino, Torino 10128, Italy
| | - C Cordioli
- Centro Sclerosi Multipla, ASST Spedali Civili di Brescia, Ospedale di Montichiari, Brescia, Italy
| | - L Moiola
- Multiple Sclerosis Center, Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - F Patti
- Department "G.F. Ingrassia", MS Center, University of Catania, Catania, Italy
| | - L Lavorgna
- Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - M Filippi
- Multiple Sclerosis Center, Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy
| | - G Borriello
- MS Center, San Pietro Hospital Fatebenefratelli, Rome, Italy
| | - E D'Amico
- Department "G.F. Ingrassia", MS Center, University of Catania, Catania, Italy
| | - C Pozzilli
- Department of Human Neurosciences, Sapienza University, Rome, Italy
| | - V Brescia Morra
- Department of Neurosciences and Reproductive and Odontostomatological Sciences, University of Naples Federico II, Via Pansini 5, Naples 810145, Italy
| | - R Lanzillo
- Department of Neurosciences and Reproductive and Odontostomatological Sciences, University of Naples Federico II, Via Pansini 5, Naples 810145, Italy.
| |
Collapse
|
3
|
Troisi Lopez E, Sorrentino P, Liparoti M, Minino R, Polverino A, Romano A, Carotenuto A, Amico E, Sorrentino G. The kinectome: A comprehensive kinematic map of human motion in health and disease. Ann N Y Acad Sci 2022; 1516:247-261. [PMID: 35838306 PMCID: PMC9796708 DOI: 10.1111/nyas.14860] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
Human voluntary movement stems from the coordinated activations in space and time of many musculoskeletal segments. However, the current methodological approaches to study human movement are still limited to the evaluation of the synergies among a few body elements. Network science can be a useful approach to describe movement as a whole and to extract features that are relevant to understanding both its complex physiology and the pathophysiology of movement disorders. Here, we propose to represent human movement as a network (that we named the kinectome), where nodes represent body points, and edges are defined as the correlations of the accelerations between each pair of them. We applied this framework to healthy individuals and patients with Parkinson's disease, observing that the patients' kinectomes display less symmetrical patterns as compared to healthy controls. Furthermore, we used the kinectomes to successfully identify both healthy and diseased subjects using short gait recordings. Finally, we highlighted topological features that predict the individual clinical impairment in patients. Our results define a novel approach to study human movement. While deceptively simple, this approach is well-grounded, and represents a powerful tool that may be applied to a wide spectrum of frameworks.
Collapse
Affiliation(s)
- Emahnuel Troisi Lopez
- Department of Motor Sciences and WellnessUniversity of Naples “Parthenope”NaplesItaly
| | | | - Marianna Liparoti
- Department of Developmental and Social PsychologyUniversity “La Sapienza” of RomeRomeItaly
| | - Roberta Minino
- Department of Motor Sciences and WellnessUniversity of Naples “Parthenope”NaplesItaly
| | - Arianna Polverino
- Institute for Diagnosis and TreatmentHermitage CapodimonteNaplesItaly
| | - Antonella Romano
- Department of Motor Sciences and WellnessUniversity of Naples “Parthenope”NaplesItaly
| | - Anna Carotenuto
- Alzheimer Unit and Movement Disorders ClinicDepartment of NeurologyCardarelli HospitalNaplesItaly
| | - Enrico Amico
- Institute of Bioengineering, Center for NeuroprostheticsEPFLGenevaSwitzerland,Department of Radiology and Medical InformaticsUniversity of Geneva (UNIGE)GenevaSwitzerland
| | - Giuseppe Sorrentino
- Department of Motor Sciences and WellnessUniversity of Naples “Parthenope”NaplesItaly,Institute for Diagnosis and TreatmentHermitage CapodimonteNaplesItaly,Institute of Applied Sciences and Intelligent SystemsCNRPozzuoliItaly
| |
Collapse
|
4
|
Carotenuto A, Fasanaro AM, Manzo V, Amenta F, Traini E. Association Between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in the Treatment of Depression in Patients with Alzheimer’s Disease. J Alzheimers Dis Rep 2022; 6:235-243. [PMID: 35719710 PMCID: PMC9198805 DOI: 10.3233/adr-200269] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2020] [Accepted: 04/27/2022] [Indexed: 11/25/2022] Open
Abstract
Background: Depressive symptoms are common in Alzheimer’s disease (AD) patients and are associated with an increased functional decline. Selective serotonin reuptake inhibitor antidepressants showed a limited efficacy. Objective: The purpose of this work was to evaluate if a higher brain cholinergic stimulation induced by the association between the acetylcholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate has any effect on depression in AD patients. Methods: Patients were selected among those recruited in the ASCOMALVA (association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in AD) trial. Depressive symptoms were investigated in 90 AD patients through the neuropsychiatric inventory at baseline and after 3, 6, 9, 12, 18, and 24 months of treatment. Patients were randomized in a group association therapy (45 subjects) receiving donepezil 10 mg plus choline alphoscerate 1,200 mg/day, and a group monotherapy (45 subjects) receiving donepezil 10 mg/day plus placebo. Based on the results of the MMSE at the recruitment patients were divided into 3 groups: severely impaired (score < 15); moderately impaired (score 19-16); mild-moderately impaired (score 24-20). Results: Depression symptoms were significantly lower (p < 0.05) in patients treated with donepezil plus choline alphoscerate compared to patients treated with donepezil alone. Subjects of the group having mild to moderate cognitive impairment were those more sensitive to the association treatment. Conclusion: Depression symptoms of AD patients in the mild to moderate stage probably could to benefit of a stronger cholinergic stimulation induced by associating donepezil with the cholinergic precursor choline alphoscerate.
Collapse
Affiliation(s)
- Anna Carotenuto
- Centre for Clinical Research, Telemedicine and Telepharmacy, University of Camerino, Camerino, Italy
- Neurology Unit, National Hospital, “A. Cardarelli”, Naples, Italy
| | | | - Valentino Manzo
- Neurology Unit, National Hospital, “A. Cardarelli”, Naples, Italy
| | - Francesco Amenta
- Centre for Clinical Research, Telemedicine and Telepharmacy, University of Camerino, Camerino, Italy
| | - Enea Traini
- Centre for Clinical Research, Telemedicine and Telepharmacy, University of Camerino, Camerino, Italy
| |
Collapse
|
5
|
Pontillo G, Tommasin S, Cuocolo R, Petracca M, Petsas N, Ugga L, Carotenuto A, Pozzilli C, Iodice R, Lanzillo R, Quarantelli M, Brescia Morra V, Tedeschi E, Pantano P, Cocozza S. A Combined Radiomics and Machine Learning Approach to Overcome the Clinicoradiologic Paradox in Multiple Sclerosis. AJNR Am J Neuroradiol 2021; 42:1927-1933. [PMID: 34531195 DOI: 10.3174/ajnr.a7274] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2020] [Accepted: 07/12/2021] [Indexed: 11/07/2022]
Abstract
BACKGROUND AND PURPOSE Conventional MR imaging explains only a fraction of the clinical outcome variance in multiple sclerosis. We aimed to evaluate machine learning models for disability prediction on the basis of radiomic, volumetric, and connectivity features derived from routine brain MR images. MATERIALS AND METHODS In this retrospective cross-sectional study, 3T brain MR imaging studies of patients with multiple sclerosis, including 3D T1-weighted and T2-weighted FLAIR sequences, were selected from 2 institutions. T1-weighted images were processed to obtain volume, connectivity score (inferred from the T2 lesion location), and texture features for an atlas-based set of GM regions. The site 1 cohort was randomly split into training (n = 400) and test (n = 100) sets, while the site 2 cohort (n = 104) constituted the external test set. After feature selection of clinicodemographic and MR imaging-derived variables, different machine learning algorithms predicting disability as measured with the Expanded Disability Status Scale were trained and cross-validated on the training cohort and evaluated on the test sets. The effect of different algorithms on model performance was tested using the 1-way repeated-measures ANOVA. RESULTS The selection procedure identified the 9 most informative variables, including age and secondary-progressive course and a subset of radiomic features extracted from the prefrontal cortex, subcortical GM, and cerebellum. The machine learning models predicted disability with high accuracy (r approaching 0.80) and excellent intra- and intersite generalizability (r ≥ 0.73). The machine learning algorithm had no relevant effect on the performance. CONCLUSIONS The multidimensional analysis of brain MR images, including radiomic features and clinicodemographic data, is highly informative of the clinical status of patients with multiple sclerosis, representing a promising approach to bridge the gap between conventional imaging and disability.
Collapse
Affiliation(s)
- G Pontillo
- From the Departments of Advanced Biomedical Sciences (G.P., L.U., E.T., S.C.).,Electrical Engineering and Information Technology (G.P., M.Q.)
| | - S Tommasin
- Department of Human Neuroscience (S.T., C.P., P.P.), Sapienza University of Rome, Rome, Italy
| | - R Cuocolo
- Clinical Medicine and Surgery (R.C.) .,Laboratory of Augmented Reality for Health Monitoring (R.C.)
| | - M Petracca
- Department of Electrical Engineering and Information Technology, and Department of Neurosciences and Reproductive and Odontostomatological Sciences (M.P., A.C., R.I., R.L., V.B.M.), University of Naples "Federico II," Naples, Italy
| | - N Petsas
- Istituto di Ricovero e Cura a Carattere Scientifico Istituto Neurologico Mediterraneo (N.P., P.P.), Pozzilli, Italy
| | - L Ugga
- From the Departments of Advanced Biomedical Sciences (G.P., L.U., E.T., S.C.)
| | - A Carotenuto
- Department of Electrical Engineering and Information Technology, and Department of Neurosciences and Reproductive and Odontostomatological Sciences (M.P., A.C., R.I., R.L., V.B.M.), University of Naples "Federico II," Naples, Italy
| | - C Pozzilli
- Department of Human Neuroscience (S.T., C.P., P.P.), Sapienza University of Rome, Rome, Italy
| | - R Iodice
- Department of Electrical Engineering and Information Technology, and Department of Neurosciences and Reproductive and Odontostomatological Sciences (M.P., A.C., R.I., R.L., V.B.M.), University of Naples "Federico II," Naples, Italy
| | - R Lanzillo
- Department of Electrical Engineering and Information Technology, and Department of Neurosciences and Reproductive and Odontostomatological Sciences (M.P., A.C., R.I., R.L., V.B.M.), University of Naples "Federico II," Naples, Italy
| | - M Quarantelli
- Electrical Engineering and Information Technology (G.P., M.Q.).,Institute of Biostructure and Bioimaging (M.Q.), National Research Council, Naples, Italy
| | - V Brescia Morra
- Department of Electrical Engineering and Information Technology, and Department of Neurosciences and Reproductive and Odontostomatological Sciences (M.P., A.C., R.I., R.L., V.B.M.), University of Naples "Federico II," Naples, Italy
| | - E Tedeschi
- From the Departments of Advanced Biomedical Sciences (G.P., L.U., E.T., S.C.)
| | - P Pantano
- Department of Human Neuroscience (S.T., C.P., P.P.), Sapienza University of Rome, Rome, Italy.,Istituto di Ricovero e Cura a Carattere Scientifico Istituto Neurologico Mediterraneo (N.P., P.P.), Pozzilli, Italy
| | - S Cocozza
- From the Departments of Advanced Biomedical Sciences (G.P., L.U., E.T., S.C.)
| |
Collapse
|
6
|
Carotenuto A, Traini E, Fasanaro AM, Battineni G, Amenta F. Tele-Neuropsychological Assessment of Alzheimer's Disease. J Pers Med 2021; 11:jpm11080688. [PMID: 34442332 PMCID: PMC8398333 DOI: 10.3390/jpm11080688] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2021] [Revised: 07/19/2021] [Accepted: 07/20/2021] [Indexed: 02/06/2023] Open
Abstract
Background: Because of the new pandemic caused by the novel coronavirus disease (COVID-19), the demand for telemedicine and telemonitoring solutions has been exponentially raised. Because of its special advantage to treat patients in an emergency without physical presence at a hospital via video conferencing, telemedicine has been used to overcome distance barriers and to improve access to special domains like neurology. In these pandemic times, telemedicine has been also employed as a support for the diagnosis and treatment of adult-onset dementia disorders including Alzheimer’s disease. Objective: In this study, we carried out a systematic literature analysis to clarify if the neuropsychological tests traditionally employed in face-to-face (FTF) contexts are reliable via telemedicine. Methods: A systematic literature search for the past 20 years (2001–2020) was carried out through the medical databases PubMed (Medline) and the Cumulative Index to Nursing and Allied Health Literature (CINAHL). The quality assessment was conducted by adopting the Newcastle Ottawa Scale (NOS) and only studies with a NOS ≥ 7 were included in this review. Results: The Mini-Mental State Examination (MMSE) results do not differ when tests are administered in the traditional FTF modality or by videoconference, and only negligible minor changes in the scoring system were noticeable. Other neuropsychological tests used to support the diagnosis of AD and dementia such as the Token Test, the Comprehension of Words and Phrases (ACWP), the Controlled Oral Word Association Test showed high reliability between the two modalities considered. No differences in the reliability concerning the living setting or education of the subjects were reported. Conclusions: The MMSE, which is the main screening test for dementia, can be administered via telemedicine with minor adaptation in the scoring system. Telemedicine use for other neuropsychological tests also resulted in general reliability and enough accuracy. Cognitive assessment by videoconference is accepted and appreciated and therefore can be used for dementia diagnosis in case of difficulties to performing FTF assessments. This approach can be useful given a personalized medicine approach for the treatment of adult-onset dementia disorders.
Collapse
Affiliation(s)
- Anna Carotenuto
- Centre for Clinical Research, Telemedicine and Telepharmacy, University of Camerino, Via Madonna delle Carceri 9, 62032 Camerino, Italy; (A.C.); (E.T.); (A.M.F.); (F.A.)
| | - Enea Traini
- Centre for Clinical Research, Telemedicine and Telepharmacy, University of Camerino, Via Madonna delle Carceri 9, 62032 Camerino, Italy; (A.C.); (E.T.); (A.M.F.); (F.A.)
| | - Angiola Maria Fasanaro
- Centre for Clinical Research, Telemedicine and Telepharmacy, University of Camerino, Via Madonna delle Carceri 9, 62032 Camerino, Italy; (A.C.); (E.T.); (A.M.F.); (F.A.)
| | - Gopi Battineni
- Centre for Clinical Research, Telemedicine and Telepharmacy, University of Camerino, Via Madonna delle Carceri 9, 62032 Camerino, Italy; (A.C.); (E.T.); (A.M.F.); (F.A.)
- Correspondence: ; Tel.: +39-333-172-8206
| | - Francesco Amenta
- Centre for Clinical Research, Telemedicine and Telepharmacy, University of Camerino, Via Madonna delle Carceri 9, 62032 Camerino, Italy; (A.C.); (E.T.); (A.M.F.); (F.A.)
- Research Department, International Radio Medical Centre (C.I.R.M.), Via dell’Architettura 41, 00144 Roma, Italy
| |
Collapse
|
7
|
De Angelis M, Casciaro B, Genovese A, Brancaccio D, Marcocci ME, Novellino E, Carotenuto A, Palamara AT, Mangoni ML, Nencioni L. Temporin G, an amphibian antimicrobial peptide against influenza and parainfluenza respiratory viruses: Insights into biological activity and mechanism of action. FASEB J 2021; 35:e21358. [PMID: 33538061 DOI: 10.1096/fj.202001885rr] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2020] [Revised: 12/18/2020] [Accepted: 12/24/2020] [Indexed: 12/22/2022]
Abstract
Treatment of respiratory viral infections remains a global health concern, mainly due to the inefficacy of available drugs. Therefore, the discovery of novel antiviral compounds is needed; in this context, antimicrobial peptides (AMPs) like temporins hold great promise. Here, we discovered that the harmless temporin G (TG) significantly inhibited the early life-cycle phases of influenza virus. The in vitro hemagglutinating test revealed the existence of TG interaction with the viral hemagglutinin (HA) protein. Furthermore, the hemolysis inhibition assay and the molecular docking studies confirmed a TG/HA complex formation at the level of the conserved hydrophobic stem groove of HA. Remarkably, these findings highlight the ability of TG to block the conformational rearrangements of HA2 subunit, which are essential for the viral envelope fusion with intracellular endocytic vesicles, thereby neutralizing the virus entry into the host cell. In comparison, in the case of parainfluenza virus, which penetrates host cells upon a membrane-fusion process, addition of TG to infected cells provoked ~1.2 log reduction of viral titer released in the supernatant. Nevertheless, at the same condition, an immunofluorescent assay showed that the expression of viral hemagglutinin/neuraminidase protein was not significantly reduced. This suggested a peptide-mediated block of some late steps of viral replication and therefore the impairment of the extracellular release of viral particles. Overall, our results are the first demonstration of the ability of an AMP to interfere with the replication of respiratory viruses with a different mechanism of cell entry and will open a new avenue for the development of novel therapeutic approaches against a large variety of respiratory viruses, including the recent SARS-CoV2.
Collapse
Affiliation(s)
- M De Angelis
- Department of Public Health and Infectious Diseases, Laboratory Affiliated to Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy
| | - B Casciaro
- Center For Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, Rome, Italy
| | - A Genovese
- Department of Public Health and Infectious Diseases, Laboratory Affiliated to Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy
| | - D Brancaccio
- Department of Pharmacy, University of Naples "Federico II", Naples, Italy
| | - M E Marcocci
- Department of Public Health and Infectious Diseases, Laboratory Affiliated to Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy
| | - E Novellino
- Department of Pharmacy, University of Naples "Federico II", Naples, Italy
| | - A Carotenuto
- Department of Pharmacy, University of Naples "Federico II", Naples, Italy
| | - A T Palamara
- Department of Public Health and Infectious Diseases, Laboratory Affiliated to Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy
| | - M L Mangoni
- Department of Biochemical Sciences, Laboratory Affiliated to Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy
| | - L Nencioni
- Department of Public Health and Infectious Diseases, Laboratory Affiliated to Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy
| |
Collapse
|
8
|
Traini E, Carotenuto A, Fasanaro AM, Amenta F. Volume Analysis of Brain Cognitive Areas in Alzheimer's Disease: Interim 3-Year Results from the ASCOMALVA Trial. J Alzheimers Dis 2021; 76:317-329. [PMID: 32508323 PMCID: PMC7369051 DOI: 10.3233/jad-190623] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Background: Cerebral atrophy is a common feature of several neurodegenerative disorders, including Alzheimer’s disease (AD). In AD, brain atrophy is associated with loss of gyri and sulci in the temporal and parietal lobes, and in parts of the frontal cortex and cingulate gyrus. Objective: The ASCOMALVA trial has assessed, in addition to neuropsychological analysis, whether the addition of the cholinergic precursor choline alphoscerate to treatment with donepezil has an effect on brain volume loss in patients affected by AD associated with cerebrovascular injury. Methods: 56 participants to the randomized, placebo-controlled, double-blind ASCOMALVA trial were assigned to donepezil + placebo (D + P) or donepezil + choline alphoscerate (D + CA) treatments and underwent brain magnetic resonance imaging and neuropsychological tests every year for 4 years. An interim analysis of 3-year MRI data was performed by voxel morphometry techniques. Results: The D + P group (n = 27) developed atrophy of the gray and white matter with concomitant increase in ventricular space volume. In the D + CA group (n = 29) the gray matter atrophy was less pronounced compared to the D + P group in frontal and temporal lobes, hippocampus, and amygdala. These morphological data are consistent with the results of the neuropsychological tests. Conclusion: Our findings indicate that the addition of choline alphoscerate to standard treatment with the cholinesterase inhibitor donepezil counters to some extent the loss in volume occurring in some brain areas of AD patients. The observation of parallel less pronounced decrease in cognitive and functional tests in patients with the same treatment suggests that the morphological changes observed may have functional relevance.
Collapse
Affiliation(s)
- Enea Traini
- Clinical Research, Telemedicine and Telepharmacy Centre, University of Camerino, Camerino, Italy
| | - Anna Carotenuto
- Clinical Research, Telemedicine and Telepharmacy Centre, University of Camerino, Camerino, Italy.,Neurology Unit, National Hospital "A. Cardarelli", Naples, Italy
| | | | - Francesco Amenta
- Clinical Research, Telemedicine and Telepharmacy Centre, University of Camerino, Camerino, Italy
| |
Collapse
|
9
|
Troisi Lopez E, Minino R, Sorrentino P, Rucco R, Carotenuto A, Agosti V, Tafuri D, Manzo V, Liparoti M, Sorrentino G. A synthetic kinematic index of trunk displacement conveying the overall motor condition in Parkinson's disease. Sci Rep 2021; 11:2736. [PMID: 33531608 PMCID: PMC7854606 DOI: 10.1038/s41598-021-82348-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2020] [Accepted: 01/15/2021] [Indexed: 12/21/2022] Open
Abstract
Parkinson's disease (PD) is characterized by motor impairment, affecting quality of life and increasing fall risk, due to ineffective postural control. To this day, the diagnosis remains based on clinical approach. Similarly, motor evaluation is based on heterogeneous, operator-dependent observational criteria. A synthetic, replicable index to quantify motor impairment is still lacking. Hence, we have designed a new measure of postural stability which assesses the trunk displacement in relation to the center of mass, that we named trunk displacement index (TDI). Twenty-three PD patients and twenty-three healthy controls underwent motor examination through a stereophotogrammetric system. A correlation analysis was performed to assess the relationship of TDI with gait parameters and clinical motor scale (UPDRS-III). The TDI sensitivity was estimated, comparing pre- and post- L-DOPA subclinical dose intake. The TDI showed significant correlations with many gait parameters and with the UPDRS-III. Furthermore, the TDI resulted capable in discriminating between off and on state in PD, whereas gait parameters failed two show any difference between those two conditions. Our results suggest that the TDI may be considered a highly sensitive biomechanical index, reflecting the overall motor condition in PD, and provided of clinical relevance due to the correlation with the clinical evaluation.
Collapse
Affiliation(s)
- Emahnuel Troisi Lopez
- Department of Motor Sciences and Wellness, University of Naples "Parthenope", Naples, Italy
| | - Roberta Minino
- Department of Motor Sciences and Wellness, University of Naples "Parthenope", Naples, Italy
| | - Pierpaolo Sorrentino
- Institut de Neurosciences Des Systemès, Aix-Marseille University, Marseille, France
- Institute of Applied Sciences and Intelligent Systems, CNR, Pozzuoli, Italy
| | - Rosaria Rucco
- Department of Motor Sciences and Wellness, University of Naples "Parthenope", Naples, Italy
- Institute of Applied Sciences and Intelligent Systems, CNR, Pozzuoli, Italy
| | - Anna Carotenuto
- Alzheimer Unit and Movement Disorders Clinic, Department of Neurology, Cardarelli Hospital, Naples, Italy
| | - Valeria Agosti
- Department of Human and Social Sciences, University of Bergamo, Bergamo, Italy
| | - Domenico Tafuri
- Department of Motor Sciences and Wellness, University of Naples "Parthenope", Naples, Italy
| | - Valentino Manzo
- Alzheimer Unit and Movement Disorders Clinic, Department of Neurology, Cardarelli Hospital, Naples, Italy
| | - Marianna Liparoti
- Department of Motor Sciences and Wellness, University of Naples "Parthenope", Naples, Italy.
| | - Giuseppe Sorrentino
- Department of Motor Sciences and Wellness, University of Naples "Parthenope", Naples, Italy
- Institute of Applied Sciences and Intelligent Systems, CNR, Pozzuoli, Italy
- Institute for Diagnosis and Care, Hermitage Capodimonte, Naples, Italy
| |
Collapse
|
10
|
Lanzillo R, Moccia M, Palladino R, Signoriello E, Carotenuto A, Maniscalco G, Saccà F, Bonavita S, Russo C, Iodice R, Petruzzo M, Sinisi L, De Angelis M, Lavorgna L, De Rosa A, Romano F, Orlando V, Ronga B, Florio C, Lus G, Brescia Morra V. Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study. Mult Scler Relat Disord 2020; 38:101871. [DOI: 10.1016/j.msard.2019.101871] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2019] [Revised: 09/08/2019] [Accepted: 11/24/2019] [Indexed: 11/24/2022]
|
11
|
Carotenuto A, Costabile T, Moccia M, Falco F, Scala M, Russo C, Saccà F, De Rosa A, Lanzillo R, Brescia Morra V. Olfactory function and cognition in relapsing–remitting and secondary-progressive multiple sclerosis. Mult Scler Relat Disord 2019; 27:1-6. [DOI: 10.1016/j.msard.2018.09.024] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2018] [Revised: 09/18/2018] [Accepted: 09/21/2018] [Indexed: 10/28/2022]
|
12
|
Jacini F, Sorrentino P, Lardone A, Rucco R, Baselice F, Cavaliere C, Aiello M, Orsini M, Iavarone A, Manzo V, Carotenuto A, Granata C, Hillebrand A, Sorrentino G. Amnestic Mild Cognitive Impairment Is Associated With Frequency-Specific Brain Network Alterations in Temporal Poles. Front Aging Neurosci 2018; 10:400. [PMID: 30574086 PMCID: PMC6291511 DOI: 10.3389/fnagi.2018.00400] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2018] [Accepted: 11/20/2018] [Indexed: 12/13/2022] Open
Abstract
There is general agreement that the neuropathological processes leading to Alzheimer’s disease (AD) begin decades before the clinical onset. In order to detect early topological changes, we applied functional connectivity and network analysis to magnetoencephalographic (MEG) data obtained from 16 patients with amnestic Mild Cognitive Impairment (aMCI), a prodromal stage of AD, and 16 matched healthy control (HCs). Significant differences between the two groups were found in the theta band, which is associated with memory processes, in both temporal poles (TPs). In aMCI, the degree and betweenness centrality (BC) were lower in the left superior TP, whereas in the right middle TP the BC was higher. A statistically significant negative linear correlation was found between the BC of the left superior TP and a delayed recall score, a sensitive marker of the “hippocampal memory” deficit in early AD. Our results suggest that the TPs, which are involved early in AD pathology and belong to the memory circuitry, have an altered role in the functional network in aMCI.
Collapse
Affiliation(s)
- Francesca Jacini
- Department of Motor Sciences and Wellness, Parthenope University of Naples, Naples, Italy.,Institute for Diagnosis and Cure Hermitage Capodimonte, Naples, Italy
| | - Pierpaolo Sorrentino
- Department of Engineering, Parthenope University of Naples, Naples, Italy.,Department of Clinical Neurophysiology and MEG Center, VU University Medical Center Amsterdam, Amsterdam, Netherlands
| | - Anna Lardone
- Department of Motor Sciences and Wellness, Parthenope University of Naples, Naples, Italy.,Institute for Diagnosis and Cure Hermitage Capodimonte, Naples, Italy
| | - Rosaria Rucco
- Department of Motor Sciences and Wellness, Parthenope University of Naples, Naples, Italy.,Institute for Diagnosis and Cure Hermitage Capodimonte, Naples, Italy
| | - Fabio Baselice
- Department of Engineering, Parthenope University of Naples, Naples, Italy
| | - Carlo Cavaliere
- Diagnostic and Nuclear Research Institute, IRCCS SDN, Naples, Italy
| | - Marco Aiello
- Diagnostic and Nuclear Research Institute, IRCCS SDN, Naples, Italy
| | - Mario Orsini
- Diagnostic and Nuclear Research Institute, IRCCS SDN, Naples, Italy
| | - Alessandro Iavarone
- Neurological and Stroke Unit, CTO Hospital-AORN Ospedale dei Colli, Naples, Italy
| | | | | | - Carmine Granata
- Institute of Applied Sciences and Intelligent Systems, CNR, Pozzuoli, Italy
| | - Arjan Hillebrand
- Department of Clinical Neurophysiology and MEG Center, VU University Medical Center Amsterdam, Amsterdam, Netherlands
| | - Giuseppe Sorrentino
- Department of Motor Sciences and Wellness, Parthenope University of Naples, Naples, Italy.,Institute for Diagnosis and Cure Hermitage Capodimonte, Naples, Italy
| |
Collapse
|
13
|
Lanzillo R, Cennamo G, Moccia M, Criscuolo C, Carotenuto A, Frattaruolo N, Sparnelli F, Melenzane A, Lamberti A, Servillo G, Tranfa F, De Crecchio G, Brescia Morra V. Retinal vascular density in multiple sclerosis: a 1‐year follow‐up. Eur J Neurol 2018; 26:198-201. [DOI: 10.1111/ene.13770] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2018] [Accepted: 08/02/2018] [Indexed: 11/28/2022]
Affiliation(s)
- R. Lanzillo
- Department of Neuroscience, Reproductive Sciences and Odontostomatology Multiple Sclerosis Clinical Care and Research Centre Federico II University Naples
| | - G. Cennamo
- Department of Public Health Federico II University Naples Italy
| | - M. Moccia
- Department of Neuroscience, Reproductive Sciences and Odontostomatology Multiple Sclerosis Clinical Care and Research Centre Federico II University Naples
- NMR Research Unit Department of Neuroinflammation Queen Square MS Centre UCL Institute of Neurology Faculty of Brain Sciences University College London London UK
| | - C. Criscuolo
- Department of Neuroscience, Reproductive Sciences and Odontostomatology Multiple Sclerosis Clinical Care and Research Centre Federico II University Naples
| | - A. Carotenuto
- Department of Neuroscience, Reproductive Sciences and Odontostomatology Multiple Sclerosis Clinical Care and Research Centre Federico II University Naples
| | - N. Frattaruolo
- Department of Neuroscience, Reproductive Sciences and Odontostomatology Multiple Sclerosis Clinical Care and Research Centre Federico II University Naples
| | - F. Sparnelli
- Department of Neuroscience, Reproductive Sciences and Odontostomatology Federico II University Naples Italy
| | - A. Melenzane
- Department of Neuroscience, Reproductive Sciences and Odontostomatology Federico II University Naples Italy
| | - A. Lamberti
- Department of Neuroscience, Reproductive Sciences and Odontostomatology Multiple Sclerosis Clinical Care and Research Centre Federico II University Naples
| | - G. Servillo
- Department of Neuroscience, Reproductive Sciences and Odontostomatology Federico II University Naples Italy
| | - F. Tranfa
- Department of Neuroscience, Reproductive Sciences and Odontostomatology Federico II University Naples Italy
| | - G. De Crecchio
- Department of Neuroscience, Reproductive Sciences and Odontostomatology Federico II University Naples Italy
| | - V. Brescia Morra
- Department of Neuroscience, Reproductive Sciences and Odontostomatology Multiple Sclerosis Clinical Care and Research Centre Federico II University Naples
| |
Collapse
|
14
|
Carotenuto A, Rea R, Traini E, Ricci G, Fasanaro AM, Amenta F. Cognitive Assessment of Patients With Alzheimer's Disease by Telemedicine: Pilot Study. JMIR Ment Health 2018; 5:e31. [PMID: 29752254 PMCID: PMC5970283 DOI: 10.2196/mental.8097] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/25/2017] [Revised: 09/29/2017] [Accepted: 02/26/2018] [Indexed: 01/18/2023] Open
Abstract
BACKGROUND Approximately 46.8 million people are living with dementia worldwide and their number will grow in the next years. Any potential treatment should be administered as early as possible because it is important to provide an early cognitive assessment and to regularly monitor the mental function of patients. Information and communication technologies can be helpful to reach and follow patients without displacing them, but there may be doubts about the reliability of cognitive tests performed by telemedicine. OBJECTIVE The purpose of this study was to evaluate the reliability of the Mini Mental State Examination (MMSE) and the Alzheimer's Disease Assessment Scale cognitive subscale (ADAS-cog) tests administered in hospital by videoconference to patients with mild to moderate Alzheimer's disease. METHODS The tests were administered to 28 Alzheimer's disease outpatients (8 male, mean age 73.88, SD 7.45 years; 20 female mean age 76.00, SD 5.40 years) recruited and followed in the Alzheimer's Unit of the A Cardarelli National Hospital (Naples, Italy) at baseline and after 6, 12, 18, and 24 months of observation. Patients were evaluated first face-to-face by a psychologist and then, after 2 weeks, by another psychologist via videoconference in hospital. RESULTS This study showed no differences in the MMSE and ADAS-cog scores when the tests were administered face-to-face or by videoconference, except in patients with more pronounced cognitive deficits (MMSE<17), in which the assessment via videoconference overestimated the cognitive impairment (face to face, MMSE mean 13.9, SD 4.9 and ADAS-cog mean 9.0, SD 3.8; videoconference, MMSE mean 42.8, SD 12.5 and ADAS-cog mean 56.9, SD 5.5). CONCLUSIONS We found that videoconferencing is a reliable approach to document cognitive stability or decline, and to measure treatment effects in patients with mild to moderate dementia. A more extended study is needed to confirm these results.
Collapse
Affiliation(s)
- Anna Carotenuto
- Clinical Research, Telemedicine and Telepharmacy Centre, School of Pharmacy, University of Camerino, Camerino, Italy
| | - Raffaele Rea
- Clinical Research, Telemedicine and Telepharmacy Centre, School of Pharmacy, University of Camerino, Camerino, Italy
| | - Enea Traini
- Clinical Research, Telemedicine and Telepharmacy Centre, School of Pharmacy, University of Camerino, Camerino, Italy
| | - Giovanna Ricci
- Bioethics and Legal Medicine Centre, School of Law, University of Camerino, Camerino, Italy
| | | | - Francesco Amenta
- Clinical Research, Telemedicine and Telepharmacy Centre, School of Pharmacy, University of Camerino, Camerino, Italy
| |
Collapse
|
15
|
Carotenuto A, Rea R, Traini E, Fasanaro AM, Ricci G, Manzo V, Amenta F. The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial. J Alzheimers Dis 2018; 56:805-815. [PMID: 28035924 DOI: 10.3233/jad-160675] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND Behavioral and psychological symptoms of dementia (BPSD) are a group of psychological reactions, psychiatric symptoms, and behaviors commonly found in Alzheimer's disease (AD). Four clusters of BPSD have been described: mood disorders (depression, anxiety, and apathy), psychotic symptoms (delusions and hallucinations), aberrant motor behaviors (pacing, wandering, and other purposeless behaviors), and inappropriate behaviors (agitation, disinhibition, and euphoria). Most of them are attributed to acetylcholine deficiency. OBJECTIVE To evaluate if a higher amount of acetylcholine obtained by associating donepezil and choline alphoscerate might have a favorable effect on BPSD. METHODS BPSD were measured at baseline and after 24 months in 113 mild/moderate AD patients, included in the double-blind randomized trial ASCOMALVA, by the Neuropsychiatric Inventory (NPI). Two matched groups were compared: group A treated with donepezil (10 mg/day) plus choline alphoscerate (1200 mg/day), and group B treated with donepezil (10 mg/day) plus placebo. RESULTS Data of NPI revealed a significant decrease of BPSD severity and distress of the caregiver in patients of group A compared with group B. Mood disorders (depression, anxiety and apathy) were significantly decreased in subjects treated with donepezil and choline alphoscerate, while their severity and frequency was increased in the other group. CONCLUSIONS Patients treated with donepezil plus choline alphoscerate showed a lower level of behavioral disturbances than subjects treated with donepezil only, suggesting that the association can have beneficial effects.
Collapse
Affiliation(s)
- Anna Carotenuto
- Clinical Research, Telemedicine and Telepharmacy Center, University of Camerino, Camerino, Italy.,Neurology Unit, National Hospital, "A. Cardarelli", Naples, Italy
| | - Raffaele Rea
- Clinical Research, Telemedicine and Telepharmacy Center, University of Camerino, Camerino, Italy.,Neurology Unit, National Hospital, "A. Cardarelli", Naples, Italy
| | - Enea Traini
- Clinical Research, Telemedicine and Telepharmacy Center, University of Camerino, Camerino, Italy
| | | | - Giovanna Ricci
- Bioethics and Legal Medicine Center, School of Law, University of Camerino, Camerino, Italy
| | - Valentino Manzo
- Neurology Unit, National Hospital, "A. Cardarelli", Naples, Italy
| | - Francesco Amenta
- Clinical Research, Telemedicine and Telepharmacy Center, University of Camerino, Camerino, Italy
| |
Collapse
|
16
|
Carotenuto A. Look beyond the door, not through the keyhole: evidence from a cognitive assessment including social cognition evaluation in multiple sclerosis. Eur J Neurol 2017; 25:205-206. [PMID: 29053891 DOI: 10.1111/ene.13482] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- A Carotenuto
- Department of Neurosciences, Reproductive Science and Odontostomatology, Federico II University, Naples, Italy.,Neurodegeneration Imaging Group, Maurice Wohl Clinical Neuroscience Institute, IoPPN, King's College London, London, UK
| |
Collapse
|
17
|
Lanzillo R, Carotenuto A, Moccia M, Saccà F, Russo CV, Massarelli M, De Rosa A, Brescia Morra V. A longitudinal real-life comparison study of natalizumab and fingolimod. Acta Neurol Scand 2017; 136:217-222. [PMID: 27976804 DOI: 10.1111/ane.12718] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/17/2016] [Indexed: 02/04/2023]
Abstract
BACKGROUND Different retrospective studies compared natalizumab and fingolimod in relapsing-remitting multiple sclerosis (RRMS), with conflicting results. We aimed to explore the prescriptive attitude and the clinical outcome of the two therapies. METHODS We retrospectively included all RRMS patients treated with natalizumab (n=101) or fingolimod (n=78) as their first second-line therapy with at least 24-month follow-up. Demographic and clinical features were recorded to calculate the propensity score (PS). Outcomes of interest were annualized relapse rate (ARR), risk of relapse, and change in the EDSS RESULTS: At baseline, natalizumab patients were younger and had a shorter disease duration, a higher number of relapse in 1 year (1yR) and 2 years (2yR) and overall (ARR-PT) pretherapy, compared to fingolimod patients. On therapy, the proportion of relapsing patients and the mean RR were similar in the two groups. However, the change in the ARR was higher in natalizumab than in fingolimod group (P<.002), but, using PS as a covariate, it was comparable (P=.960). Similarly, the change in EDSS was significantly different for the two groups (P<.004), but not after adjusting for the PS (P=.321). CONCLUSION We observed a comparable efficacy on ARR reduction and on EDSS progression with natalizumab and fingolimod correcting through PS, suggesting that the efficacy difference observed before correction might derive from the clinical attitude in prescribing natalizumab in more active MS patients in real life.
Collapse
Affiliation(s)
- R. Lanzillo
- Department of Neurosciences, Reproductive and Odontostomatological Sciences; Multiple Sclerosis Clinical Care and Research Centre; Federico II University; Naples Italy
| | - A. Carotenuto
- Department of Neurosciences, Reproductive and Odontostomatological Sciences; Multiple Sclerosis Clinical Care and Research Centre; Federico II University; Naples Italy
| | - M. Moccia
- Department of Neurosciences, Reproductive and Odontostomatological Sciences; Multiple Sclerosis Clinical Care and Research Centre; Federico II University; Naples Italy
| | - F. Saccà
- Department of Neurosciences, Reproductive and Odontostomatological Sciences; Multiple Sclerosis Clinical Care and Research Centre; Federico II University; Naples Italy
| | - C. V. Russo
- Department of Neurosciences, Reproductive and Odontostomatological Sciences; Multiple Sclerosis Clinical Care and Research Centre; Federico II University; Naples Italy
| | - M. Massarelli
- Department of Neurosciences, Reproductive and Odontostomatological Sciences; Multiple Sclerosis Clinical Care and Research Centre; Federico II University; Naples Italy
| | - A. De Rosa
- Department of Neurosciences, Reproductive and Odontostomatological Sciences; Multiple Sclerosis Clinical Care and Research Centre; Federico II University; Naples Italy
| | - V. Brescia Morra
- Department of Neurosciences, Reproductive and Odontostomatological Sciences; Multiple Sclerosis Clinical Care and Research Centre; Federico II University; Naples Italy
| |
Collapse
|
18
|
Carotenuto A, Iodice R, Petracca M, Inglese M, Cerillo I, Cocozza S, Saiote C, Brunetti A, Tedeschi E, Manganelli F, Orefice G. Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex ®. Acta Neurol Scand 2017; 135:442-448. [PMID: 27500463 DOI: 10.1111/ane.12660] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/14/2016] [Indexed: 11/28/2022]
Abstract
BACKGROUND Spasticity in multiple sclerosis (MS) results from an imbalance of inputs from descending pathways to the spinal motor circuits, as well as from a damage of the corticospinal tract (CST). OBJECTIVES To assess CST impairment in MS patients with and without spasticity and to evaluate its evolution under Sativex® treatment. METHODS Ten MS patients with spasticity ("cases") underwent clinical (EDSS, 9-hole Peg, Ashworth scale, Timed 25-Foot Walk, and NRS for spasticity), MRI (CST fractional anisotropy [FA]), and electrophysiological (central motor conduction time [CMCT] and H/M ratio) evaluations at baseline and after 12 months. We selected 20 MS patients without spasticity as control group at baseline. RESULTS At baseline, cases showed a lower CST FA (0.492±0.045 vs 0.543±0.047; P=.01) and a higher CMCT (P=.001) compared to the control group. No correlations were found between clinical, electrophysiological, and MRI features. After 12 months, cases showed a decrease in non-prevalent degree of impairment (PDI) side FA (0.502±0.023 vs 0.516±0.033; P=.01) without differences for electrophysiological features compared to baseline. Treatment with Sativex® resulted in a reduction of NRS for spasticity (P=.01). CONCLUSIONS We confirm the presence of CST impairment in MS patients with spasticity. We did not identify structural/electrophysiological correlates that could explain Sativex® clinical effect.
Collapse
Affiliation(s)
- A. Carotenuto
- Department of Neurosciences, Reproductive and Odontostomatological Sciences; Federico II University of Naples; Naples Italy
| | - R. Iodice
- Department of Neurosciences, Reproductive and Odontostomatological Sciences; Federico II University of Naples; Naples Italy
| | - M. Petracca
- Department of Neurosciences, Reproductive and Odontostomatological Sciences; Federico II University of Naples; Naples Italy
- Department of Neurology, Radiology, Neuroscience; Icahn School of Medicine; Mount Sinai NY USA
| | - M. Inglese
- Department of Neurology, Radiology, Neuroscience; Icahn School of Medicine; Mount Sinai NY USA
| | - I. Cerillo
- Department of Neurosciences, Reproductive and Odontostomatological Sciences; Federico II University of Naples; Naples Italy
| | - S. Cocozza
- Department of Advanced Biomedical Sciences; Federico II University of Naples; Naples Italy
| | - C. Saiote
- Department of Neurology; Icahn School of Medicine; Mount Sinai NY USA
| | - A. Brunetti
- Department of Advanced Biomedical Sciences; Federico II University of Naples; Naples Italy
| | - E. Tedeschi
- Department of Advanced Biomedical Sciences; Federico II University of Naples; Naples Italy
| | - F. Manganelli
- Department of Neurosciences, Reproductive and Odontostomatological Sciences; Federico II University of Naples; Naples Italy
| | - G. Orefice
- Department of Neurosciences, Reproductive and Odontostomatological Sciences; Federico II University of Naples; Naples Italy
| |
Collapse
|
19
|
Lanzillo R, Di Somma C, Quarantelli M, Carotenuto A, Pivonello C, Moccia M, Cianflone A, Marsili A, Puorro G, Saccà F, Russo CV, De Luca Picione C, Ausiello F, Colao A, Brescia Morra V. Growth hormone/IGF-1 axis longitudinal evaluation in clinically isolated syndrome patients on interferon β-1b therapy: stimulation tests and correlations with clinical and radiological conversion to multiple sclerosis. Eur J Neurol 2016; 24:446-449. [PMID: 27982500 DOI: 10.1111/ene.13207] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2016] [Accepted: 10/25/2016] [Indexed: 12/14/2022]
Abstract
BACKGROUND AND PURPOSE Growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis abnormalities in multiple sclerosis (MS) suggest their role in its pathogenesis. Interferon β (IFN-β) efficacy could be mediated also by an increase of IGF-1 levels. A 2-year longitudinal study was performed to estimate the prevalence of GH and/or IGF-1 deficiency in clinically isolated syndrome (CIS) patients and their correlation with conversion to MS in IFN treated patients. METHODS Clinical and demographic features of CIS patients were collected before the start of IFN-β-1b. IGF-1 levels and GH response after arginine and GH releasing hormone + arginine stimulation tests were assessed. Clinical and magnetic resonance imaging evaluations were performed at baseline, 1 year and 2 years. RESULTS Thirty CIS patients (24 female) were enrolled. At baseline, four patients (13%) showed a hypothalamic GH deficiency (GHD), whilst no one had a pituitary GHD. Baseline demographic, clinical and radiological data were not related to GHD, whilst IGF-1 levels were inversely related to age (P < 0.001) and GH levels (P = 0.03). GH and IGF-1 serum mean levels were not significantly modified after 1 and 2 years of treatment in the whole group, although 3/4 GHD patients experienced a normalization of GH levels, whilst one dropped out. After 2 years of treatment 13/28 (46%) patients converted to MS. The presence of GHD and GH and IGF-1 levels were not predictive of relapses, new T2 lesions or conversion occurrence. CONCLUSIONS Growth hormone/IGF-1 axis function was found to be frequently altered in CIS patients, but this was not related to MS conversion. Patients experienced an improvement of GHD during IFN therapy. Longer follow-up is necessary to assess its impact on disease progression.
Collapse
Affiliation(s)
- R Lanzillo
- Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy
| | | | - M Quarantelli
- Biostructure and Bioimaging Institute (IBB), National Research Council (CNR), Naples, Italy
| | - A Carotenuto
- Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy
| | | | - M Moccia
- Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy
| | - A Cianflone
- Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy
| | - A Marsili
- Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy
| | - G Puorro
- Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy
| | - F Saccà
- Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy
| | - C V Russo
- Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy
| | - C De Luca Picione
- Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy
| | - F Ausiello
- Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy
| | | | - V Brescia Morra
- Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy
| |
Collapse
|
20
|
Moccia M, Quarantelli M, Lanzillo R, Cocozza S, Carotenuto A, Carotenuto B, Alfano B, Prinster A, Triassi M, Nardone A, Palladino R, Brunetti A, Brescia Morra V. Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression. Eur J Neurol 2016; 24:195-204. [DOI: 10.1111/ene.13183] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2016] [Accepted: 09/16/2016] [Indexed: 01/30/2023]
Affiliation(s)
- M. Moccia
- Department of Neuroscience, Reproductive Science and Odontostomatology; Multiple Sclerosis Clinical Care and Research Center; University Federico II; Naples
| | - M. Quarantelli
- Biostructure and Bioimaging Institute; National Research Council; Naples
| | - R. Lanzillo
- Department of Neuroscience, Reproductive Science and Odontostomatology; Multiple Sclerosis Clinical Care and Research Center; University Federico II; Naples
| | - S. Cocozza
- Neuroradiology Unit; Department of Advanced Biomedical Sciences; University Federico II; Naples
| | - A. Carotenuto
- Department of Neuroscience, Reproductive Science and Odontostomatology; Multiple Sclerosis Clinical Care and Research Center; University Federico II; Naples
| | - B. Carotenuto
- Neuroradiology Unit; Department of Advanced Biomedical Sciences; University Federico II; Naples
| | - B. Alfano
- Biostructure and Bioimaging Institute; National Research Council; Naples
| | - A. Prinster
- Biostructure and Bioimaging Institute; National Research Council; Naples
| | - M. Triassi
- Department of Public Health; University Federico II; Naples Italy
| | - A. Nardone
- Department of Public Health; University Federico II; Naples Italy
| | - R. Palladino
- Department of Public Health; University Federico II; Naples Italy
- Department of Primary Care and Public Health; Imperial College; London UK
| | - A. Brunetti
- Neuroradiology Unit; Department of Advanced Biomedical Sciences; University Federico II; Naples
| | - V. Brescia Morra
- Department of Neuroscience, Reproductive Science and Odontostomatology; Multiple Sclerosis Clinical Care and Research Center; University Federico II; Naples
| |
Collapse
|
21
|
Iodice R, Carotenuto A, Dubbioso R, Cerillo I, Santoro L, Manganelli F. Multimodal evoked potentials follow up in multiple sclerosis patients under fingolimod therapy. J Neurol Sci 2016; 365:143-6. [DOI: 10.1016/j.jns.2016.04.026] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2016] [Revised: 03/09/2016] [Accepted: 04/14/2016] [Indexed: 10/21/2022]
|
22
|
Orefice N, Carotenuto A, Mangone G, Bues B, Rehm R, Cerillo I, Saccà F, Calignano A, Orefice G. Assessment of neuroactive steroids in cerebrospinal fluid comparing acute relapse and stable disease in relapsing-remitting multiple sclerosis. J Steroid Biochem Mol Biol 2016; 159:1-7. [PMID: 26892094 DOI: 10.1016/j.jsbmb.2016.02.012] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/28/2015] [Revised: 02/09/2016] [Accepted: 02/11/2016] [Indexed: 11/30/2022]
Abstract
Previous studies have reported an involvement of neuroactive steroids as neuroprotective and anti-inflammatory agents in neurological disorders such as multiple sclerosis (MS); an analysis of their profile during a specific clinical phase of MS is largely unknown. The pregnenolone (PREG), dehydroepiandrosterone (DHEA), and allopregnanolone (ALLO) profile was evaluated in cerebrospinal fluid (CSF) in relapsing-remitting multiple sclerosis (RR-MS) patients as well as those in patients affected by non-inflammatory neurological (control group I) and without neurological disorders (control group II). An increase of PREG and DHEA values was shown in CSF of male and female RR-MS patients compared to those observed in both control groups. The ALLO values were significantly lower in female RR-MS patients than those found in male RR-MS patients and in female without neurological disorder. During the clinical relapse, we observed female RR-MS patients showing significantly increased PREG values compared to female RR-MS patients in stable phase, while their ALLO values showed a significant decrease compared to male RR-MS patients of the same group. Male RR-MS patients with gadolinium-enhanced lesions showed PREG and DHEA values higher than those found in female RR-MS patients with gadolinium-enhanced lesions. Similary, male RR-MS patients with gadolinium-enhanced lesions showed PREG and DHEA values higher than male without gadolinium-enhanced lesions. Female RR-MS patients with gadolinium-enhanced lesions showed DHEA values higher than those found in female RR-MS patients with gadolinium-enhanced lesions. Male and female RR-MS patients with gadolinium-enhanced lesions showed ALLO values higher than those found in respective gender groups without gadolinium-enhanced lesions. ALLO values were lower in male than in female RR-MS patients without gadolinium-enhanced lesions. Considering the pharmacological properties of neuroactive steroids and the observation that neurological disorders influence their concentrations, these endogenous compounds may have an important role as prognostic factors of the disease and used as markers of MS activity such as relapses.
Collapse
Affiliation(s)
- Ns Orefice
- Department of Pharmacy, "Federico II" University, Naples, Italy.
| | - A Carotenuto
- Department of Neurosciences, Reproductive Sciences and Odontostomatology, "Federico II" University, Naples, Italy.
| | - G Mangone
- Clinical Investigation Center for Neurosciences, Pitié-Salpêtrière Hospital, Paris, France.
| | - B Bues
- University Medical Center, Göttingen, Germany.
| | - R Rehm
- University Medical Center, Göttingen, Germany.
| | - I Cerillo
- Department of Neurosciences, Reproductive Sciences and Odontostomatology, "Federico II" University, Naples, Italy.
| | - F Saccà
- Department of Neurosciences, Reproductive Sciences and Odontostomatology, "Federico II" University, Naples, Italy.
| | - A Calignano
- Department of Pharmacy, "Federico II" University, Naples, Italy.
| | - G Orefice
- Department of Neurosciences, Reproductive Sciences and Odontostomatology, "Federico II" University, Naples, Italy.
| |
Collapse
|
23
|
Cennamo G, Romano MR, Vecchio EC, Minervino C, Della Guardia C, Velotti N, Carotenuto A, Montella S, Orefice G, Cennamo G. Anatomical and functional retinal changes in multiple sclerosis. Eye (Lond) 2015; 30:456-62. [PMID: 26681148 DOI: 10.1038/eye.2015.256] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2014] [Accepted: 10/31/2015] [Indexed: 12/24/2022] Open
Abstract
AIMS The aims of this study was to report anatomical changes of the ganglion cell complex (GCC), retinal nerve fiber layer (RNFL) thickness, and macular volume in patients with multiple sclerosis (MS). We also investigated the correlation between anatomical and functional changes in terms of visual acuity and macular sensitivity investigated and visual fields. METHODS Prospective comparative study included 105 eyes of 53 consecutive patients. The patients were divided into two groups: group A included 56 eyes of 28 patients with diagnosis of MS; group B involved 49 eyes of 25 healthy patients. The examination included Goldmann tonometry, biomicroscopic and fundus oculi examination, retinography, GCC examination, circumpapillary RNFL (cpRNFL), and macular volume. The functional test included measurement of best-corrected visual acuity (BCVA), visual field, and MP. RESULTS MS group showed a significant reduced GCC, cpRNFL, macular volume, BCVA, visual field, and macular sensitivity compared with the control group (P<0.001). This reduction was more representative (P<0.001) in patients with MS complicated by optic neuritis (ON). We found in the MS group a strong correlation between GCC thickness and macular volume (r(2)=0.59, P<0.001) and also between GCC and RNFL thickness (r(2)=0.48, P<0.001). There was also a correlation between macular sensitivity and macular volume reduction (r(2)=0.25, P<0.001) and also between RNFL and macular volume (r(2)=0.43, P<0.001). CONCLUSIONS The significant statistical evidence and the strong correlation between anatomical and functional parameters support the use of OCT and MP in the evaluation, treatment, and follow-up of patients diagnosed with MS.
Collapse
Affiliation(s)
- G Cennamo
- Eye Clinic, Dipartimento di Neuroscienze e Scienze, Riproduttive ed Odontostomatologiche, Università degli Studi Federico II, Naples, Italy
| | - M R Romano
- Eye Clinic, Dipartimento di Neuroscienze e Scienze, Riproduttive ed Odontostomatologiche, Università degli Studi Federico II, Naples, Italy
| | - E C Vecchio
- Eye Clinic, Dipartimento di Neuroscienze e Scienze, Riproduttive ed Odontostomatologiche, Università degli Studi Federico II, Naples, Italy
| | - C Minervino
- Eye Clinic, Dipartimento di Neuroscienze e Scienze, Riproduttive ed Odontostomatologiche, Università degli Studi Federico II, Naples, Italy
| | - C Della Guardia
- Eye Clinic, Dipartimento di Neuroscienze e Scienze, Riproduttive ed Odontostomatologiche, Università degli Studi Federico II, Naples, Italy
| | - N Velotti
- Eye Clinic, Dipartimento di Neuroscienze e Scienze, Riproduttive ed Odontostomatologiche, Università degli Studi Federico II, Naples, Italy
| | - A Carotenuto
- Neurological Clinic, Dipartimento di Neuroscienze e Scienze, Riproduttive ed Odontostomatologiche, Università degli Studi Federico II, Naples, Italy
| | - S Montella
- Neurological Clinic, Dipartimento di Neuroscienze e Scienze, Riproduttive ed Odontostomatologiche, Università degli Studi Federico II, Naples, Italy
| | - G Orefice
- Neurological Clinic, Dipartimento di Neuroscienze e Scienze, Riproduttive ed Odontostomatologiche, Università degli Studi Federico II, Naples, Italy
| | - G Cennamo
- Eye Clinic, Dipartimento di Neuroscienze e Scienze, Riproduttive ed Odontostomatologiche, Università degli Studi Federico II, Naples, Italy
| |
Collapse
|
24
|
Signoriello E, Lanzillo R, Brescia Morra V, Di Iorio G, Fratta M, Carotenuto A, Lus G. Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis. Mult Scler 2015; 22:921-5. [PMID: 26453682 DOI: 10.1177/1352458515604381] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2015] [Accepted: 08/13/2015] [Indexed: 11/15/2022]
Abstract
BACKGROUND Natalizumab is an effective therapy in relapsing-remitting multiple sclerosis (RRMS), as it reduces lymphocyte transmigration through the blood-brain barrier (BBB) and induces lymphocytosis. OBJECTIVES To analyse natalizumab-induced lymphocytosis (NIL) as a biomarker of drug efficacy. MATERIALS AND METHODS We enrolled 50 relapsing-remitting (RR) and progressive-relapsing (PR) natalizumab-treated patients who had received at least 16 infusions and had been tested for lymphocyte count 24 hours before each administration. Clinical, MRI and hematological data were collected. Patients were divided into responders and sub-optimal responders according to the experience of at least one clinical and/or instrumental relapse during the treatment. RESULTS In 15 (30%) patients, an instrumental/clinical (14) or only instrumental (one) relapse occurred. We found a statistically significant difference in the mean percentage of the lymphocytes between the two groups over the first ten administrations (p=0.04). The comparison between the time-to-relapse in the groups with high and low levels of lymphocytes showed that the group with a low NIL had a greater risk of relapse (p=0.03). CONCLUSIONS We suggest that NIL could be a biomarker of therapeutic efficacy in patients with RRMS treated with natalizumab, and that the risk of relapse may be higher in patients with a lower-than-expected NIL.
Collapse
Affiliation(s)
- E Signoriello
- Multiple Sclerosis Center, II Division of Neurology, Department of Clinical and Experimental Medicine, Second University of Naples, Italy
| | - R Lanzillo
- Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University-School of Medicine, Italy
| | - V Brescia Morra
- Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University-School of Medicine, Italy
| | - G Di Iorio
- Multiple Sclerosis Center, II Division of Neurology, Department of Clinical and Experimental Medicine, Second University of Naples, Italy
| | - M Fratta
- Multiple Sclerosis Center, II Division of Neurology, Department of Clinical and Experimental Medicine, Second University of Naples, Italy
| | - A Carotenuto
- Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University-School of Medicine, Italy
| | - G Lus
- Multiple Sclerosis Center, II Division of Neurology, Department of Clinical and Experimental Medicine, Second University of Naples, Italy
| |
Collapse
|
25
|
Rea R, Carotenuto A, Traini E, Fasanaro AM, Manzo V, Amenta F. Apathy Treatment in Alzheimer’s Disease: Interim Results of the ASCOMALVA Trial. J Alzheimers Dis 2015; 48:377-83. [DOI: 10.3233/jad-141983] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Affiliation(s)
- Raffaele Rea
- Centre for Clinical Research, Telemedicine and Telepharmacy, University of Camerino, Camerino, Italy
- Neurology Unit, National Hospital, “A. Cardarelli”, Naples, Italy
| | - Anna Carotenuto
- Centre for Clinical Research, Telemedicine and Telepharmacy, University of Camerino, Camerino, Italy
- Neurology Unit, National Hospital, “A. Cardarelli”, Naples, Italy
| | - Enea Traini
- Centre for Clinical Research, Telemedicine and Telepharmacy, University of Camerino, Camerino, Italy
| | | | - Valentino Manzo
- Neurology Unit, National Hospital, “A. Cardarelli”, Naples, Italy
| | - Francesco Amenta
- Centre for Clinical Research, Telemedicine and Telepharmacy, University of Camerino, Camerino, Italy
| |
Collapse
|
26
|
Amenta F, Carotenuto A, Fasanaro AM, Rea R, Traini E. The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer's Disease) Trial: interim results after two years of treatment. J Alzheimers Dis 2015; 42 Suppl 3:S281-8. [PMID: 24898643 DOI: 10.3233/jad-140150] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Cholinesterase inhibitors (ChE-Is) are used for symptomatic treatment of mild-to-moderate Alzheimer's disease (AD), but long-term effects of these compounds are mild and not always obvious. Preclinical studies have shown that combination of ChE-Is and the cholinergic precursor choline alphoscerate increases brain acetylcholine levels more effectively than single compounds alone. ASCOMALVA (Effect of association between a ChE-I and choline alphoscerate on cognitive deficits in AD associated with cerebrovascular injury) is a double-blind trial investigating if the ChE-I donepezil and choline alphoscerate in combination are more effective that donepezil alone. The trial has recruited AD patients suffering from ischemic brain damage documented by neuroimaging and has completed 2 years of observation in 113 patients of the 210 planned. Patients were randomly allotted to an active treatment group (donepezil + choline alphoscerate) or to a reference group (donepezil + placebo). Cognitive functions were assessed by the Mini-Mental State Evaluation and Alzheimer's Disease Assessment Scale Cognitive subscale. Daily activity was evaluated by the basic and instrumental activities of daily living tests. Behavioral symptoms were assessed by the Neuropsychiatric Inventory. Over the 24-month observation period, patients of the reference group showed a moderate time-dependent worsening in all the parameters investigated. Treatment with donepezil plus choline alphoscerate significantly slowed changes of the different items analyzed. These findings suggest that the combination of choline alphoscerate with a ChE-I may prolong/increase the effectiveness of cholinergic therapies in AD with concomitant ischemic cerebrovascular injury.
Collapse
Affiliation(s)
- Francesco Amenta
- Centro Ricerche Cliniche, Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Camerino, Italy
| | - Anna Carotenuto
- Centro Ricerche Cliniche, Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Camerino, Italy
| | - Angiola Maria Fasanaro
- Unità Valutativa Alzheimer e Malattie Involutive Cerebrali, Azienda Ospedaliera di Rilievo Nazionale A. Cardarelli, Napoli, Italy
| | - Raffaele Rea
- Centro Ricerche Cliniche, Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Camerino, Italy
| | - Enea Traini
- Centro Ricerche Cliniche, Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Camerino, Italy
| |
Collapse
|
27
|
Moccia M, Lanzillo R, Palladino R, Maniscalco GT, De Rosa A, Russo C, Massarelli M, Carotenuto A, Postiglione E, Caporale O, Triassi M, Brescia Morra V. The Framingham cardiovascular risk score in multiple sclerosis. Eur J Neurol 2015; 22:1176-83. [PMID: 25912468 DOI: 10.1111/ene.12720] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2015] [Accepted: 02/26/2015] [Indexed: 01/13/2023]
Abstract
BACKGROUND AND PURPOSE Cardiovascular risk factors can increase the risk of multiple sclerosis (MS) and modify its course. However, such factors possibly interact, determining a global cardiovascular risk. Our aim was to compare the global cardiovascular risk of subjects with and without MS with the simplified 10-year Framingham General Cardiovascular Disease Risk Score (FR) and to evaluate its importance on MS-related outcomes. METHODS Age, gender, smoking status, body mass index, systolic blood pressure, type II diabetes and use of antihypertensive medications were recorded in subjects with and without MS to estimate the FR, an individualized percentage risk score estimating the 10-year likelihood of cardiovascular events. RESULTS In total, 265 MS subjects were identified with 530 matched controls. A t test showed similar FR in cases and controls (P = 0.212). Secondary progressive MS presented significantly higher FR compared to relapsing-remitting MS (P < 0.001). Linear regression analysis showed a direct relationship between FR and Expanded Disability Status Scale (P < 0.001) and MS Severity Scale (P < 0.001). CONCLUSION The FR, evaluating the global cardiovascular health by the interaction amongst different risk factors, relates to MS disability, severity and course.
Collapse
Affiliation(s)
- M Moccia
- Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Naples, Italy
| | - R Lanzillo
- Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Naples, Italy
| | - R Palladino
- Department of Public Health, Federico II University, Naples, Italy.,Department of Primary Care and Public Health, Imperial College, London, UK
| | - G T Maniscalco
- Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Naples, Italy.,Neurology Clinic, AORN 'Antonio Cardarelli', Naples, Italy
| | - A De Rosa
- Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Naples, Italy
| | - C Russo
- Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Naples, Italy
| | - M Massarelli
- Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Naples, Italy
| | - A Carotenuto
- Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Naples, Italy
| | - E Postiglione
- Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Naples, Italy
| | - O Caporale
- Department of Public Health, Federico II University, Naples, Italy
| | - M Triassi
- Department of Public Health, Federico II University, Naples, Italy
| | - V Brescia Morra
- Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Naples, Italy
| |
Collapse
|
28
|
Carotenuto A, Fasanaro AM, Molino I, Sibilio F, Saturnino A, Traini E, Amenta F. The Psychological General Well-Being Index (PGWBI) for assessing stress of seafarers on board merchant ships. Int Marit Health 2014; 64:215-20. [PMID: 24408143 DOI: 10.5603/imh.2013.0007] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2013] [Accepted: 12/17/2013] [Indexed: 11/25/2022] Open
Abstract
BACKGROUND In their working activity, seafarers are exposed to high levels of stress that should be accuratelyinvestigated, measured, followed up and, if possible, countered. This is also required by regulations recently entered into force such as the Maritime Labour Convention 2006, recommending to consider special physiological or psychological problems created by the shipboard environment. The choice of the tools for this evaluation is challenging, and a common basic standard usable in a large scale should be identified. AIM The aim of this study was to evaluate: 1) the suitability of the Psychological General Well-Being Index (PGWBI) questionnaire conducted on board for assessing stress in the sailing seafarers, 2) The presenceof stress in seafarers of different categories (deck officers, engine officers, deck crew, engine crew, chiefstewards/catering staff) monitored by the PGWBI. MATERIALS AND METHODS 162 male seafarers on board of 7 tankers belonging to the same shipping companywere evaluated through the PGWB questionnaire. Analysis of variance (ANOVA) was used to analyse thedifferences in the scores of the questionnaire. RESULTS Engine officers exhibited significantly higher anxiety levels than the deck or engine crew, andshowed lower satisfaction than the deck crew. Deck and engine officers revealed higher self-control levelsthan the engine crew. Chief stewards/catering staff showed lower vitality levels than the deck crew. CONCLUSIONS Deck or engine officers should achieve a greater self-control than the crew and this is documentedby the present study. Our findings support the view that management responsibility is more often associated with higher levels of stress. In our opinion, the PGWB questionnaire is a reasonable compromise forobtaining a global evaluation of psychological conditions, including stress of seafarers. It should be therefore considered as a large scale tool for assessing the well-being and eventual stress levels of sailing seafarers.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Francesco Amenta
- Centre for Clinical Research, Telemedicine and Telepharmacy, University of Camerino, Camerino, Italy; Department of Study and Research, International Radio Medical Centre (CIRM), Rome, Italy.
| |
Collapse
|
29
|
Amenta F, Carotenuto A, Fasanaro AM, Rea R, Traini E. The ASCOMALVA trial: Association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: Interim results. J Neurol Sci 2012; 322:96-101. [DOI: 10.1016/j.jns.2012.07.003] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2012] [Revised: 06/06/2012] [Accepted: 07/02/2012] [Indexed: 11/26/2022]
|
30
|
Itro A, Lupo G, Carotenuto A, Filipi M, Cocozza E, Fiengo G, Marra A. Management of temporomandibular joint ankylosis: a case report of joint replacement with piezoelectric surgery. Minerva Stomatol 2012; 61:329-335. [PMID: 22976516] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
AIM Temporomandibular joint (TMJ) ankylosis is a joint disorder which refers to bone or fibrous adhesion of the anatomic joint components and the ensuing loss of function. This report describes the management of a case of bilateral TMJ ankylosis in a 20-year-old patient with prosthetic replacement with the aid of a piezoelectric instrument (MECTRON (R). METHODS The right ankylotic mass was surgically removed and replaced by a custom-made prosthesis based on data obtained from three-dimensional computed tomography (CT) reconstruction of the skull of the patient using a stereolithography model. RESULTS At six months postoperative, the opening of the mouth was stable at 36 mm and imaging studies (CT and magnetic resonance imaging [MRI]) showed a great condylar prosthesis and surrounding tissues in addition to partial remodeling of the left TMJ. CONCLUSION In this patient, despite the bilateral ankylosis, it was sufficient to intervene only on the right TMJ, which presented a serious bone block, with mobilization since surgery gradually restored the anatomical and functional conditions of the left TMJ compatible with normal activities of mastication and speech.
Collapse
Affiliation(s)
- A Itro
- Maxillo-Facial Surgery, Naples Second University, Naples, Italy
| | | | | | | | | | | | | |
Collapse
|
31
|
Itro A, Lupo G, Marra A, Carotenuto A, Cocozza E, Filipi M, D'Amato S. The piezoelectric osteotomy technique compared to the one with rotary instruments in the surgery of included third molars. A clinical study. Minerva Stomatol 2012; 61:247-253. [PMID: 22669054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
AIM The purpose of this study is to compare surgical times, the saving of bonytissues, the postoperative course of the extraction of included third molars in patients treated with piezoelectric surgery compared to those treated with conventional rotary instruments. METHODS The study included 140 patients with upper and lower third molars included. 70 of them were treated with osteotomy using conventional rotary instruments (Group 1) and 70 more with osteotomy through piezosurgery Mectron® (GROUP 2). The treatment protocol was the same for both groups. The time of surgery and the saving of bonytissues in the intra-operative have been estimated; moreover, 24-48-72 hours and 7 days after the surgery, two other parameters have been estimated: facial swelling and trismus. The swelling, trismus and the saving of bony tissues were assessed by a surgery gauge. RESULTS The average surgical time was 15 minutes in Group 1 and 20 minutes in Group 2. The savings of bonytissues was greater in Group 2 than in group 1 by 2.7 mm. The average facial swelling was 6.23 mm for group 1 and 2.86 mm for group 2 24 hours after the surgery, of 5.22 mm for group 1 and 1.76 mm for group 2 48 hours after the intervention, of 3.75 mm for Group 1 and 0.85 for group 2 72 hours after the surgery, of 0.86 mm for group 1 and 0.12 for group 2. The average trismus was of 14.76 mm in Group 1 and 11.15 mm in Group 2. Statistical analysis showed a significant reduction of swelling, trismus and a bigger saving of bony tissues in Group 2 and a reduction in surgical time in Group 1. CONCLUSION The osteotomy technique with a piezoelectric instrument has produced a significant reduction in facial swelling, trismus and a bigger saving of bony tissues than with conventional rotary instruments. A slight lengthening in terms of surgical time has been recorded, compared to the use of conventional rotary instruments.
Collapse
Affiliation(s)
- A Itro
- University of Naples, Italy.
| | | | | | | | | | | | | |
Collapse
|
32
|
Itro A, Lupo G, Carotenuto A, Filipi M, Cocozza E, Marra A. Benefits of piezoelectric surgery in oral and maxillofacial surgery. Review of literature. Minerva Stomatol 2012; 61:213-224. [PMID: 22576446] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Piezoelectric surgery is based on the use of ultrasound for the cutting of bones. It represents an innovative technique, as it offers the maxillofacial surgeon the opportunity of making precise bone cuts without damaging any soft tissue, minimizing the invasiveness of surgical procedure, and the opportunity of working in a field which is almost totally blood-free. It reduces the impact on soft tissues (vessels and nerves) which lie adjacent to the areas of treatment. Compared to traditional methods, it enables optimal healing because it reduces the postsurgery swelling and discomfort. In this article the authors realized a review of the literature.
Collapse
Affiliation(s)
- A Itro
- School of Maxillofacial Surgery, Naples, Italy
| | | | | | | | | | | |
Collapse
|
33
|
Lanzillo R, Bonavita S, Quarantelli M, Vacca G, Lus G, Amato L, Carotenuto A, Tedeschi G, Orefice G, Brescia Morra V. Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice. Neurol Sci 2012; 34:521-8. [DOI: 10.1007/s10072-012-1088-8] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2011] [Accepted: 04/06/2012] [Indexed: 10/28/2022]
|
34
|
Carotenuto A, Molino I, Fasanaro AM, Amenta F. Psychological stress in seafarers: a review. Int Marit Health 2012; 63:188-194. [PMID: 24595974] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2013] [Indexed: 06/03/2023] Open
Abstract
BACKGROUND Seafaring is a particular profession, in which workers are usually exposed to several stressors that are related to the different duties on board ships. This paper has reviewed the main publications on different factors affecting seafarers with the purpose of identifying specific stress factors related to a particular duty on board. MATERIALS AND METHODS A literature search was conducted using the online databases PubMed and OvidSP. A survey on health, stress, and fatigue of Australian Seafarers published by the Australian Maritime Safety Authority (AMSA) fulfilling the selection criteria was also examined. This publication provided relevant data obtained from a large sample of seafarers. RESULTS Our analysis confirmed that seafaring is associated with mental, psychosocial, and physical stressors. The most important factors were separation from family, loneliness on board, fatigue, multi-nationality, limited recreation activity, and sleep deprivation. The AMSA report gave a more detailed analysis on lifestyle and relevant factors inducing psychological distress. Stressors affecting seafarers working in the engine room were different from those involving the deck crew. Sleep quality and duration were reported to be poor mainly in pilots, whereas deck crew tended to be less adherent to physical exercise and healthy lifestyle recommendations. CONCLUSIONS Seafaring is still associated with relevant mental health risks. Information on known stress factors on board should be provided to seafarers to help them in lowering stress perception. Strategies for coping with "inevitable" stress conditions should also be investigated and developed. Strategies to decrease risks of stress should be directed to the different categories of seafarers, and the results of specific interventions should be evaluated.
Collapse
|
35
|
Grossi D, Carotenuto A, Trojano L, Manzo V, Fasanaro AM. Do frontal dysfunctions play a role in visual hallucinations in Alzheimer's disease as in Parkinson's disease? A comparative study. ACTA ACUST UNITED AC 2011. [DOI: 10.3922/j.psns.2011.3.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
36
|
Abstract
Urotensin-II (U-II) is a "somatostatin-like" cyclic neuropeptide which was originally isolated from goby fish urophysis, and subsequently identified in other species, including man. The interest in human U-II (hU-II) has grown enormously in the last few years, following the identification of a specific human receptor (formerly identified as the GPR14/SENR orphan receptor), now referred to as UT receptor. The U-II/UT system seems to play an important role in cardiovascular functions. hU-II vasoconstrictive potency is reported to be an order of magnitude greater than that of endothelin-1 (ET-1), which would make it the most potent mammalian vasoconstrictor identified to date. hU-II also exerts potent inotropic effects in the human heart in vitro. On the basis of its spectrum of activities, hU-II has been suggested to modulate cardiovascular homeostasis and possibly to be involved in certain cardiovascular pathologies. Central nervous effects of U-II have also been described, in particular, intracerebroventricular administration promotes anxiogenic-like behaviors in rodents. Furthermore, UT receptor overexpression has been observed in some tumor cell lines. Therefore, specific and selective UT receptor antagonists provide useful tools for investigating the (patho)physiological role(s) of the U-II/UT receptor system. In this review we aim to provide an overview of the research in the area of UT receptor antagonists as well as the progress in understanding the role of the U-II/UT system in human (patho)physiology.
Collapse
Affiliation(s)
- A Carotenuto
- Department of Pharmaceutical and Toxicological Chemistry, University of Naples Federico II, Via D. Montesano, 49 - 80131 - Naples, Italy.
| | | | | | | |
Collapse
|
37
|
Lama T, Campiglia P, Carotenuto A, Auriemma L, Gomez-Monterrey I, Novellino E, Grieco P. A novel route to synthesize Freidinger lactams by micowave irradiation*. ACTA ACUST UNITED AC 2005; 66:231-5. [PMID: 16218990 DOI: 10.1111/j.1399-3011.2005.00292.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The incorporation of a Freidinger-like lactam structure into the backbone of peptides has been proven to be an useful strategy in the design of a variety of conformationally restricted targets. Several different strategies have been developed toward Freidinger lactams but no one resulted to be completely facile. Here, we report an efficient strategy that involves the iodo-derivatives in side chain of an appropriate amino acid used as electrophilic agent, and the standard solid phase peptide synthesis assisted by microwave irradiation. The methodology developed could be useful to perform Freidinger-like lactams with defined stereochemistry for routine use in solid phase peptide chemistry.
Collapse
Affiliation(s)
- T Lama
- Department of Pharmaceutical and Toxicological Chemistry, University of Naples Federico II, I-80131 Naples, Italy
| | | | | | | | | | | | | |
Collapse
|
38
|
Itro A, Difalco P, Carotenuto A. [Tooth replantation after traumatic exarticulation. Present therapeutic orientations and future perspectives]. Minerva Stomatol 2003; 52:289-300. [PMID: 12874533] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/03/2023]
Abstract
Replantation is a method in which an avulsed dental element is replaced into its alveolar socket. The dental traumatic exarticulation occurs in any age, but most frequently in the juvenile population. The aim of this paper is to rewiew the risks and benefits of tooth replantation and to discuss the present therapeutic orientations and future perspectives for avulsion management.
Collapse
Affiliation(s)
- A Itro
- Dipartimento Universitario di Patologia della Testa e del Collo, del Cavo Orale e della Comunicazione Audio-Verbale, Seconda Università degli Studi di Napoli, Napoli, Italy.
| | | | | |
Collapse
|
39
|
Itro A, Carotenuto A, Pepe GB. Localized osteodysplasia of the mandible in a seven-year-old child: a case report. Eur J Paediatr Dent 2003; 4:37-9. [PMID: 12870987] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/03/2023]
Abstract
AIM This report concerns the most recent knowledge on osteodysplasies, anomalies in the development of the bone tissue, that may concern one or more skeleton segments affecting children. CASE REPORT The case of a 7-year-old patient is reported, whose left hemimandible showed a radio transparency with a size of 10 x 7 mm. After the usual preliminary diagnostic investigations, it was decided to carry out an ablation. The neoplastic formation was completely enucleated using a conservative operation technique.
Collapse
Affiliation(s)
- A Itro
- Department of Pedodontics, II University of Naples, Italy
| | | | | |
Collapse
|
40
|
Itro A, Santagata M, Carotenuto A, Nicoletti G, Tartaro GP. [Squamous cell carcinoma of the lip. Retrospective analysis of 42 cases]. Minerva Stomatol 2003; 52:123-6. [PMID: 12783065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/02/2023]
Abstract
BACKGROUND To examine to what extent physicians follow a regional guidelines for the diagnosis, staging, treatment and follow-up of patients with squamous cell carcinoma of the lower and upper lip. METHODS DESIGN retrospective analysis of data from the medical records of 42 patients diagnosed with squamous cell carcinoma of the lower and upper lip during the period 1990-2000. SETTING Department of head and neck pathology, oral cavity and audio-verbal communication of Naples University. PARTICIPANTS the data were collected by this Department. RESULTS In accordance with the TNM system, the 50% of cases was in stage T1, 33% in T2, 14% in T3. In few cases (3%) the lesion was in stage T4. All cases were in M0 and only 8% of cases presented nodal disease at diagnosis (N1). The type of treatment in relation to age was in agreement with the guidelines in 34% of cases. Of the 42 surgically-treated patients, only 4 showed, after 12 months, a local recurrence. CONCLUSIONS Prognosis is good if squamous carcinoma is diagnosed early.
Collapse
Affiliation(s)
- A Itro
- Dipartimento Universitario di Patologia della Testa e del Collo del Cavo Orale e della Comunicazione Audio-Verbale, Seconda Università degli Studi di Napoli, Napoli, Italy
| | | | | | | | | |
Collapse
|
41
|
Carotenuto A, D'Ursi AM, Nardi E, Papini AM, Rovero P. Conformational analysis of a glycosylated human myelin oligodendrocyte glycoprotein peptide epitope able to detect antibody response in multiple sclerosis. J Med Chem 2001; 44:2378-81. [PMID: 11428934 DOI: 10.1021/jm010811t] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Myelin oligodendrocyte glycoprotein (MOG), a minor myelin component, is an important central nervous system specific target autoantigen for primary demyelination in autoimmune diseases such as multiple sclerosis (MS). The native structure of MOG presents a glycosylation site at position 31 (Asn(31)). It has been recently described that glycosylation of a MOG peptide epitope improved the detection of specific autoantibodies in sera of MS patients. The solution conformational behavior of two MOG derived peptides-hMOG(30-50) (1) and the glycosylated analogue [Asn(31)(N-beta-Glc)]hMOG(30-50) (2)-were investigated through NMR analysis in a water/HFA solution. Conformational studies revealed that peptides 1 and 2 adopted similar conformations in this environment. In particular, they showed strong propensity to assume a well-defined amphipatic structure encompassing residues 41-48. The N-terminal region resulted to be almost completely unstructured for both peptides. The presence in 1 of a low populated Asx-turn conformation characteristic of the Asn-Xaa-Thr glycosylation sites was the only conformational difference between peptides 1 and 2. Thus, the specific antibody recognition of peptide 2 is most likely driven by direct interactions of the antibody binding site with the Asn-linked sugar moiety.
Collapse
Affiliation(s)
- A Carotenuto
- Department of Pharmaceutical Sciences, University of Salerno, I-84084 Fisciano, Italy
| | | | | | | | | |
Collapse
|
42
|
Crescenzi O, Carotenuto A, D'Ursi AM, Tancredi T, D'Alessio G, Avitabile F, Picone D. 1H and 15N sequential assignment and secondary structure of the monomeric N67D mutant of bovine seminal ribonuclease. J Biomol NMR 2001; 20:289-290. [PMID: 11519752 DOI: 10.1023/a:1011294812364] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
|
43
|
Huisman JG, Carotenuto A, Labrijn AF, Papavoine CH, Laman JD, Schellekens MM, Koppelman MH, Hilbers CW. Recognition properties of V3-specific antibodies to V3 loop peptides derived from HIV-1 gp120 presented in multiple conformations. Biochemistry 2000; 39:10866-76. [PMID: 10978173 DOI: 10.1021/bi0004504] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
To identify structural constraints and amino acid sequences important for antibody recognition of the third variable domain (V3) of HIV-1 gp120, we have studied the solution conformation of three 35-mer circular V3 loop peptides derived from HIV-1 strains which differ in syncytium- (SI) and non-syncytium-inducing (NSI) capacity. In addition to 2D NMR and CD analyses, fluid- and solid-phase immunoassays were performed using V3-specific antibodies to V3 peptides and gp120 derived from different strains of HIV-1. NMR and CD spectroscopy indicated that circular and linear V3 loops exist in water as a dynamic ensemble of multiple conformations. Amino acid substitutions and biochemical modifications of the V3 loop were found to affect antibody binding depending on the presentation of the antigens. From NMR observations and immunological experiments, we provide evidence for a V3 loop specific monoclonal antibody interaction which is directed predominantly against linear epitopes rather than against discontinuous epitopes. The absence of a single defined solution conformation of 35-mer circular V3 peptides should be taken into account when using V3-related peptides to investigate structural elements in the V3 domain of the gp120 envelope protein of HIV-1 involved in biological processes of the virus.
Collapse
Affiliation(s)
- J G Huisman
- CLB, Sanquin Blood Supply Foundation, Laboratory for Clinical and Experimental Immunology, Department of Pathophysiology of Plasma Proteins, Amsterdam, The Netherlands
| | | | | | | | | | | | | | | |
Collapse
|
44
|
Itro A, Carotenuto A, Aquino S, Vestuto A. Metastases to the human mandible. Minerva Stomatol 1999; 48:543-52. [PMID: 10768014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
Abstract
Two clinical cases are reported of mandibular swelling caused by metastatic jaw neoplasms. They analyse. The clinical characteristics of the swelling are analysed and all laboratory and radiographic tests performed are examined. It is concluded that metastatic localisations in the maxillofacial bone are very rare, but that the mandible is certainly the most frequent site. The authors also highlight the fact that the presence of metastatic lesions in the jaw may be the first symptom of the neoplastic disease.
Collapse
Affiliation(s)
- A Itro
- Institute of Facial and Maxillary Surgery, Faculty of Medicine and Surgery, University of Naples II
| | | | | | | |
Collapse
|
45
|
Whitehead B, Tessari M, Carotenuto A, van Bergen en Henegouwen PM, Vuister GW. The EH1 domain of Eps15 is structurally classified as a member of the S100 subclass of EF-hand-containing proteins. Biochemistry 1999; 38:11271-7. [PMID: 10471276 DOI: 10.1021/bi990922i] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The Eps15 homology (EH) domain is a protein-protein interaction module that binds to proteins containing the asparagine-proline-phenylalanine (NPF) or tryptophan/phenylalanine-tryptophan (W/FW) motif. EH domain-containing proteins serve important roles in signaling and processes connected to transport, protein sorting, and organization of subcellular structure. Here, we report the solution structure of the apo form of the EH1 domain of mouse Eps15, as determined by high-resolution multidimensional heteronuclear NMR spectroscopy. The polypeptide folds into six alpha-helices and a short antiparallel beta-sheet. Additionally, it contains a long, structured, topologically unique C-terminal loop. Helices 2-5 form two EF-hand motifs. Structural similarity and Ca(2+) binding properties lead to classification of the EH1 domain as a member of the S100 subclass of EF-hand-containing proteins, albeit with a unique set of interhelical angles. Binding studies using an eight-residue NPF-containing peptide derived from RAB, the cellular cofactor of the HIV Rev protein, show a hydrophobic peptide-binding pocket formed by conserved tryptophan and leucine residues.
Collapse
Affiliation(s)
- B Whitehead
- Nijmegen NSR Center for Molecular Structure, Design and Synthesis, Laboratory of Biophysical Chemistry, University of Nijmegen, The Netherlands
| | | | | | | | | |
Collapse
|
46
|
Abstract
An investigation of the extracts from bulbs of Allium porrum L. has led to the isolation of four spirostanol saponins. Two of them are new compounds and have been identified as: (25R)-5 alpha-spirostan-3 beta, 6 beta-diol 3-O-{O-beta-D-glucopyranosyl-(1-->2)-O-[beta-D-xylopyranosyl-(1-->3)]-O- beta -D-glucopyranosyl-(1-->4)-beta-D-galactopyranoside} (3) and (25R)-5 alpha-spirostan-3 beta,6 beta-diol 3-O-{O-beta-D-glucopyranosyl-(1-->3)-O-beta-D-glucopyranosyl-(1-->2)-O- [beta-D-xylopyranosyl-(1-->3)]-O-beta-D-glucopyranosyl-(1-->4)-beta-D- galactopyranoside} (4). The isolated compounds were evaluated for their antifungal activity.
Collapse
Affiliation(s)
- A Carotenuto
- Dipartimento di Chimica delle Sostanze Naturali, Università di Napoli Federico II, Naples, Italy
| | | | | | | |
Collapse
|
47
|
Carotenuto A, Tessari M, Whitehead B, Aelen JM, van Bergen en Henegouwen PM, Vuister GW. Sequence-specific 1H, 13C and 15N assignment and secondary structure of the apo EH2 domain of mouse Eps15. J Biomol NMR 1999; 14:97-98. [PMID: 10382315 DOI: 10.1023/a:1008394326526] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
|
48
|
Carotenuto A, Fattorusso E, Lanzotti V, Magno S, Carnuccio R, Iuvone T. Antiproliferative sesterterpenes from the Caribbean sponge Cacospongia cf. linteiformis. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1998; 119:119-23. [PMID: 9669079 DOI: 10.1016/s0742-8413(97)00197-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Two new sesterterpenes, lintenolides F (6 a, b) and G (7 a, b), were isolated from the Caribbean sponge Cacospongia cf. linteiformis. Their stereostructures were determined using spectroscopic and chemical methods. The new compounds (6 a, b and 7 a, b) and the related compounds lintenolides A-E (1 a, b-5 a, b), previously isolated from the sponge, exhibited antiproliferative activity on four cell lines.
Collapse
Affiliation(s)
- A Carotenuto
- Dipartimento di Chimica delle Sostanze Naturali, Università degli Studi di Napoli Federico II, Italy
| | | | | | | | | | | |
Collapse
|
49
|
Carotenuto A, Fattorusso E, Lanzotti V, Magno S, De Feo V, Carnuccio R, D'Acquisto F. Porrigenins A and B, novel cytotoxic and antiproliferative sapogenins isolated from Allium porrum. J Nat Prod 1997; 60:1003-1007. [PMID: 9358643 DOI: 10.1021/np960657r] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
Four new sapogenins, porrigenins A (2a) and B (3a), identified as (25R)-5 alpha-spirostan-2 beta,3 beta,6 beta-triol and (25R)-2-oxo-5 alpha-spirostan-3 beta,6 beta-diol, respectively, and neoporrigenins A (2b) and B (3b) were also isolated from Allium porrum. In addition, the known agigenin (1a) and its 25S epimer, neoagigenin (1b), were also identified. Their structure elucidation was provided by comprehensive spectroscopic analyses. Compounds 1a, 2a, and 3a exhibited cytotoxicity and high antiproliferative activity on four different tumor cell lines in vitro.
Collapse
Affiliation(s)
- A Carotenuto
- Dipartimento di Chimica delle Sostanze Naturali, Università degli Studi di Napoli Federico II, Italy
| | | | | | | | | | | | | |
Collapse
|
50
|
Abstract
An investigation of the extracts from Allium neapolitanum has led to the isolation of 13 flavonoid glycosides, based on kaempferol, quercetin and isorhamnetin. Four of them are new compounds and have been identified as: kaempferol 3-O-[[2-O-alpha-L-rhamnopyranosyl-4-O-beta-D-glucopyranosyl]-beta-D- glucopyranoside]], isorhamnetin 3-O-[[2-O-alpha-L-rhamnopyranosyl-6-O-beta- D-glucopyranosyl]-beta-D-glucopyranoside], isorhamnetin 3-O-[[2-O-alpha-L-rhamnopyranosyl-6-O-beta-D-glycopyranosyl] beta-D-glucopyranoside]-7-O-beta-D-glucopyranoside and isorhamnetin 3-O-[[2-O-alpha-L-rhamnopyranosyl-6-O-beta-D-gentiobiosyl]- beta-D-glucopyranoside]]. The isolated compounds were evaluated for their anti-aggregation human platelet activity.
Collapse
Affiliation(s)
- A Carotenuto
- Dipartimento di Chimica delle Sostanze Naturali, Università di Napoli Federico II, Italy
| | | | | | | | | | | |
Collapse
|